Tdap Vaccine in Post-Partum Women

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 26, 2012

Primary Completion Date

August 28, 2015

Study Completion Date

August 28, 2015

Conditions
DiphtheriaPertussisTetanus
Interventions
BIOLOGICAL

Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum phosphate

55 postpartum subjects receive a single intramuscular (IM) 0.5 mL dose of Adacel® (Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed).

Trial Locations (1)

37232-2573

Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01711645 - Tdap Vaccine in Post-Partum Women | Biotech Hunter | Biotech Hunter